| |
Patients
|
ME positive
| |
|---|
|
Characteristic
|
No (%)
|
%
|
P value
|
|---|
|
Age (y)
| | |
NS
|
|
≤60
|
39 (51.3)
|
87.2
| |
|
>60
|
37 (48.7)
|
73.0
| |
|
Sex
| | |
NS
|
|
Male
|
60 (78.9)
|
78.3
| |
|
Female
|
16 (21.1)
|
87.5
| |
|
Status of Hepatitis
| | | |
|
HBsAg positive
|
62 (81.6)
|
85.5
|
NS
|
|
HCVAb positive
|
3 (3.9)
|
33.3
| |
|
Others
|
11 (14.5)
|
63.6
| |
|
AFP level (ng/ml)
| | |
<0.01
|
|
Normal
|
43 (56.6)
|
69.8
| |
|
Elevated
|
33 (43.4)
|
93.9
| |
|
Tumor size (cm)
| | |
NS
|
|
≤5
|
41 (53.9)
|
78.0
| |
|
>5
|
35 (46.1)
|
82.9
| |
|
TNM stage
| | |
NS
|
|
I
|
42 (55.3)
|
83.3
| |
|
II
|
34 (44.7)
|
76.5
| |
|
Platelets (G/L)
| | |
NS
|
|
<100
|
11 (14.5)
|
81.8
| |
|
≥100
|
65 (85.5)
|
80.0
| |
|
AST level (U/L)
| | |
NS
|
|
≤40
|
54 (71.1)
|
85.2
| |
|
>40
|
22 (28.9)
|
68.2
| |
|
ALT level (U/L)
| | |
NS
|
|
≤40
|
49 (71.1)
|
81.6
| |
|
>40
|
27 (28.9)
|
77.8
| |
|
GGT level (U/L)
| | |
NS
|
|
≤55
|
43 (56.6)
|
81.4
| |
|
>55
|
33 (43.4)
|
78.8
| |
|
Albumin level(g/L)
| | |
NS
|
|
≤35
|
8 (10.5)
|
75.0
| |
|
>35
|
68 (89.5)
|
80.9
| |
|
BIL (μmol/L)
| | |
NS
|
|
≤17.1
|
59 (77.6)
|
78.0
| |
|
>17.1
|
17 (22.4)
|
88.2
| |
|
PT(s)
| | |
NS
|
|
≤13.3
|
55 (72.4)
|
83.6
| |
|
>13.3
|
21 (27.6)
|
71.4
| |
|
Tumor grade
| | |
<0.01
|
|
1
|
6 (7.9)
|
16.7
| |
|
2
|
43 (56.6)
|
79.1
| |
|
3
|
27 (35.5)
|
96.3
| |
|
All patients
|
76 (100)
|
80.3
|
--
|
- Abbreviations: HBsAg = hepatitis B surface antigen; HCV Ab = hepatitis C virus antibody; AFP = serum α-fetoprotein; AST = serum aspartate aminotransferase level; ALT = serum alanine aminotransferase level; GGT = serum γ-glutamyltransferase; BIL = serum total bilirubin level; PT = prothrombin time; NS = not significant.
